S100A7 IHC signature-based assay

· Proteocyte Diagnostics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S100A7 IHC signature-based assay, covering 2024-11-07 to 2024-11-07. Get the full timeline:

Most recent: Clinical Trial Update: Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment